
Ceva commits to improving preventative health strategies for Vietnam’s rapidly growing livestock sector
Ceva Santé Animale signed several agreements with the Vietnam Department of Animal Health (DAH) to accelerate the implementation of preventive health strategies, including the research and development of new vaccines for Vietnamese livestock sector.
Salmonella vaccine now available to UK and Irish pig producers
Pig producers in the UK and Ireland have a new means of defense in the fight against salmonella with the launch of a highly effective salmonella vaccine that has already been well-proven in Germany and Poland.
World Veterinary Association and Ceva Santé Animale enlarge the scope of the Global Animal Welfare Awards by adding new award categories
Ceva partners with Biotecon Diagnostics to introduce a real-time test kit to fight growing problem of salmonella on pig farms
A new real-time diagnostic kit that will help pig producers fight salmonella infections on their farms has been launched at the SafePork scientific symposium in Berlin.
Ceva’s acquisition of IDT swine vaccines delivers early promise with salmonella vaccine go-ahead in several European countries
Ceva will launch Salmoporc in Austria, Belgium, Czech Republic, Denmark, Hungary, Ireland, Italy, Netherlands, Portugal, Romania, Slovak Republic, United Kingdom through the remainder of 2019.
Ceva completes acquisition of IDT veterinary business assets
IDT’s strong range of swine vaccines will strengthen Ceva’s rapidly growing presence in this segment.
Global Animal Welfare Awards highlight the special role veterinarians play in protecting the health and welfare of animals
Veterinarians from around the world, who have made significant contributions to the promotion of animal welfare, have been honoured in the 2019 Global Animal Welfare Awards.
Ceva Sante Animale announces the launch of ForcerisTM, the first approved injectable combination of gleptoferron and toltrazuril in Europe
ForcerisTM received the first marketing authorisation from the European Medicines Agency (EMA) for this innovative combination of gleptoferron and toltrazuril to treat neonatal piglets.
Ceva Japan celebrates 10 years of constant innovation
Chairman & Ceva CEO Marc Prikazsky visited Ceva Japan to celebrate the 10th anniversary of the company's Yokohama R&D center.
Ceva announces changes to Global Manufacturing and Supply, Innovation & R&D leadership
As Ceva finalizes its latest 2020-2025 strategic plan, the company recently made the following significant changes to its leadership team.
WVA Animal Welfare Award 2019
World Veterinary Association and Ceva Santé Animale recognize
veterinarians and veterinary students for their exemplary work in protecting and promoting Animal Welfare.
2nd WVA Animal Welfare Awards
The 2nd WVA Animal Welfare Awards supported by Ceva puts the welfare of animals’ center stage as 5 veterinarians from Brazil, Canada, China, Senegal and Sweden are rewarded for their outstanding work to protect and promote best practices in animal welfare.
Spotlight the future
Ceva to host Global Swine Webinar on Respiratory Diseases on May 8
Breaking €1 billion for the first time, Ceva Santé Animale consolidates its position as the leading French player in the global animal health market
This performance consolidates its position as the 6th largest animal health company and leading French multinational in the sector.
Animal Welfare a major focus as the World’s veterinarians meet in Korea
Ceva Phylaxia inaugurates state of the art vaccine plant to support “Innovation with Impact” growth plan
WVA Animal Welfare Awards 2017 supported by Ceva Santé Animale
Ceva reinforces its position in China and swine through new joint-venture with EBVAC
Ceva Santé Animale confirms its circle of virtuous growth in 2016
Ceva: Best Company in Europe winner Animal Pharm awards 2016
Contact:
Contact us using the following form.